Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Completed · Phase 2 · Has a placebo group

Conditions studied: Glaucoma, Ocular Hypertension, Eye Disease

In brief

The objective of this dose-escalation study is to evaluate the safety, tolerability and efficacy of AMA0076 in reduction of intraocular pressure in subjects with ocular hypertension or primary open-angle glaucoma.

Key facts

Study ID

NCT01693315

Run by

Amakem, NV

People needed

82

Starts

2012-09-01

Expected to finish

2013-07-01

Last updated by the study team

2013-07-17

Who can join

Age: 30 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Artesia Clinical Site - Site 02 — Artesia, California, United States
• Inglewood Clinical Site - Site 03 — Inglewood, California, United States
• Petaluma Clinical Site - Site 05 — Petaluma, California, United States
• New Haven Clinical Site - Site 01 — New Haven, Connecticut, United States
• Atlanta Clinical Site - Site 04 — Atlanta, Georgia, United States
• High Point Clinical Site - Site 06 — High Point, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.